TLRY Tilray Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TLRY

Price (delayed)

$1.73

Market cap

$1.34B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.44

Enterprise value

$1.67B

Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, ...

Highlights
Tilray's gross profit has soared by 185% YoY and by 42% from the previous quarter
Tilray's gross margin has soared by 128% YoY and by 33% from the previous quarter
Tilray's quick ratio has increased by 8% from the previous quarter but it has decreased by 8% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.tilray.com/
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of TLRY
Market
Shares outstanding
774.03M
Market cap
$1.34B
Enterprise value
$1.67B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.38
Price to sales (P/S)
1.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.25
Earnings
Revenue
$743.25M
EBIT
-$310.8M
EBITDA
-$186.62M
Free cash flow
-$46.66M
Per share
EPS
-$0.44
Free cash flow per share
-$0.06
Book value per share
$4.52
Revenue per share
$0.99
TBVPS
$1.69
Balance sheet
Total assets
$4.21B
Total liabilities
$869.82M
Debt
$481.62M
Equity
$3.36B
Working capital
$302.11M
Liquidity
Debt to equity
0.14
Current ratio
1.92
Quick ratio
0.96
Net debt/EBITDA
-1.8
Margins
EBITDA margin
-25.1%
Gross margin
28%
Net margin
-47.4%
Operating margin
-35.6%
Efficiency
Return on assets
-8.2%
Return on equity
-10.5%
Return on invested capital
-24%
Return on capital employed
-8%
Return on sales
-41.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TLRY stock price

How has the Tilray stock price performed over time
Intraday
0.58%
1 week
-4.95%
1 month
-9.9%
1 year
-28.22%
YTD
-24.78%
QTD
-29.96%

Financial performance

How have Tilray's revenue and profit performed over time
Revenue
$743.25M
Gross profit
$208.16M
Operating income
-$264.7M
Net income
-$351.95M
Gross margin
28%
Net margin
-47.4%
Tilray's gross profit has soared by 185% YoY and by 42% from the previous quarter
Tilray's gross margin has soared by 128% YoY and by 33% from the previous quarter
The operating margin has soared by 88% YoY and by 82% from the previous quarter
The operating income has surged by 85% year-on-year and by 81% since the previous quarter

Growth

What is Tilray's growth rate over time

Valuation

What is Tilray stock price valuation
P/E
N/A
P/B
0.38
P/S
1.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.25
The EPS has soared by 86% year-on-year and by 80% since the previous quarter
The price to book (P/B) is 83% lower than the 5-year quarterly average of 2.2 and 5% lower than the last 4 quarters average of 0.4
TLRY's price to sales (P/S) is 83% less than its 5-year quarterly average of 10.2 and 16% less than its last 4 quarters average of 2.1
TLRY's revenue is up by 25% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Tilray business performance
The ROS has soared by 86% year-on-year and by 79% since the previous quarter
The ROIC has soared by 80% YoY and by 78% from the previous quarter
The company's return on assets has surged by 76% YoY and by 75% QoQ
The company's return on equity has surged by 75% YoY and by 75% QoQ

Dividends

What is TLRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TLRY.

Financial health

How did Tilray financials performed over time
Tilray's current ratio has increased by 19% YoY and by 18% QoQ
The total liabilities has contracted by 10% YoY and by 7% from the previous quarter
The debt is 86% less than the equity
Tilray's debt to equity has decreased by 22% YoY and by 13% QoQ
The debt has contracted by 20% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.